Dr. Neil Quigley, vice president of Geneuity Clinical Research Services, recently gained licensure with the State of Tennessee as a Medical Laboratory Director in Molecular Diagnostics.
Quigley completed the board certification requirements in molecular diagnostics prescribed by the American Board of Bioanalysis (ABB) in July 2009. Tennessee state license grants Quigley the ability to review and sign out clinical molecular diagnostic test results.
Candidates certified by ABB must hold a doctoral degree and have four years experience and demonstrated proficiency in their respective areas of concentration. In addition, they must also receive strong recommendations by their peers.
For more information about Geneuity’s advanced technologies and services, please call 866-895-1810 or visit www.geneuity.com.
Geneuity provides innovative clinical laboratory testing services for biomarker analysis and therapeutic evaluation in Preclinical through Phase III clinical trials. Geneuity specializes in custom assay design and validation for pharmaceutical and biotech companies, in vitro device manufacturers and CROs.
Geneuity offers technical and professional expertise in quantitative PCR, DNA and protein multiplex analyses, single nucleotide polymorphism (SNP) characterization, DNA sequencing, gene expression analysis, immunohistochemistry, flow cytometry, cytogenetics, anatomic pathology and routine central laboratory testing.
Geneuity is a division of Molecular Pathology Laboratory Network, Inc. (MPLN), a privately held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, women’s health, prenatal care, medical genetics and pharmacogenetics and infectious disease.
Geneuity and MPLN are GLP compliant, certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, New York, Florida and Maryland.